Literature DB >> 7001502

Present status of chemotherapy and chemopropylaxis of human trypanosomiasis in the Eastern Hemisphere.

F I Apted.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7001502     DOI： 10.1016/0163-7258(80)90035-2

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  11 in total

1.  Sleeping sickness in Uganda: a thin line between two fatal diseases.

Authors:  Kim Picozzi; Eric M Fèvre; Martin Odiit; Mark Carrington; Mark C Eisler; Ian Maudlin; Susan C Welburn
Journal:  BMJ       Date:  2005-11-26

2.  Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis.

Authors:  Antoaneta Y Sokolova; Susan Wyllie; Stephen Patterson; Sandra L Oza; Kevin D Read; Alan H Fairlamb
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191

3.  Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-alpha-difluoromethylornithine and standard trypanocides.

Authors:  C J Bacchi; H C Nathan; N Yarlett; B Goldberg; P P McCann; A Sjoerdsma; M Saric; A B Clarkson
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

4.  Activity of cationically substituted bis-benzimidazoles against experimental Pneumocystis carinii pneumonia.

Authors:  R R Tidwell; S K Jones; N A Naiman; L C Berger; W B Brake; C C Dykstra; J E Hall
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

5.  Anti-Pneumocystis activities of aromatic diamidoxime prodrugs.

Authors:  J E Hall; J E Kerrigan; K Ramachandran; B C Bender; J P Stanko; S K Jones; D A Patrick; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

6.  Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats.

Authors:  P D Walzer; J Foy; J Runck; P Steele; M White; R S Klein; B A Otter; R J Sundberg
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; C K Kim; J Foy; M J Linke; M T Cushion
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

8.  The use of 2-substituted 5-nitroimidazoles in the treatment of chronic murine Trypanosoma brucei infections with central nervous system involvement.

Authors:  F W Jennings; G M Urquhart; P K Murray; B M Miller
Journal:  Z Parasitenkd       Date:  1984

9.  Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness.

Authors:  Irene Kuepfer; Caecilia Schmid; Mpairwe Allan; Andrew Edielu; Emma P Haary; Abbas Kakembo; Stafford Kibona; Johannes Blum; Christian Burri
Journal:  PLoS Negl Trop Dis       Date:  2012-08-28

10.  Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation.

Authors:  Tao Sun; Yi Zhang
Journal:  Nucleic Acids Res       Date:  2008-02-07       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.